Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGAM | O43451 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | SI | P14410 | 1/20 | 0.41 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | NLRP3 | Q96P20 | 3/20 | 0.31 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | PPID | Q08752 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25779016 | 0.87 | MGAM (0.39) | MGAMGAASIMGAM2ALOX15 | |
| SCHEMBL30620779 | 0.76 | GAA (0.41) | MGAMGAASIMGAM2ALOX15 | |
| SCHEMBL31359626 | 0.74 | MGAM (0.46) | MGAMGAASIMGAM2ALOX15 | |
| SCHEMBL31359625 | 0.74 | MGAM (0.46) | MGAMGAASIMGAM2ALOX15 | |
| SCHEMBL26625940 | 0.72 | MGAM (0.43) | MGAMGAASIMGAM2ALOX15 | |
| SCHEMBL26625931 | 0.70 | — | — | |
| SCHEMBL25288073 | 0.68 | — | — | |
| SCHEMBL27843171 | 0.68 | MMP8 (0.49) | MGAMGAASIMGAM2ALDH1A1 | |
| Malonic Acid Diethyl Ester SCHEMBL9472390 | 0.67 | GAA (0.68) | MGAMGAASIMGAM2ALOX15 | |
| SCHEMBL1979452 | 0.67 | GAA (0.68) | MGAMGAASIMGAM2ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4514769-B1 | MUSKY ODORANT | FIRMENICH & CIE (CH) | 2026-04-15 | — | — | EP | disclosed |
| US-20250263629-A1 | MUSKY ODORANT | FIRMENICH SA (CH) | 2025-08-21 | — | — | US | disclosed |
| EP-4514769-A1 | MUSKY ODORANT | Firmenich SA (CH) | 2025-03-05 | — | — | EP | disclosed |
| WO-2023209139-A1 | MUSKY ODORANT | FIRMENICH SA (CH) | 2023-11-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250263629-A1 | MUSKY ODORANT | TRPA1, MSMO1, MSH2 | MGAM 1233/4885GAA 4088/4885SI 2379/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.